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ABSTRACT 
Objective: Cissus quadrangularis, a perennial plant of grape family is traditionally used as an herbal medicine for treating inflammation caused by 
hemorrhoids, gastric ulcer and bone disorders. COX-2 is an oxidoreductase enzyme having a role in inflammatory responses. The objective of this 
study was to show the drug-likeness and the binding of Cissus quadrangularis derived biologically active compounds against the inflammation 
associated target COX-2 enzyme. 
Methods: The 3D structure of COX-2 enzyme protein structure was taken from PDB database (PDB ID: 6cox). The structures of plant derived compounds 
were retrieved from the PubChem database. The Lipinski’s properties of about 16 compounds from Cissus quadrangularis were checked and those which 
satisfied the Lipinski’s rule of five were subjected to docking experiments. Docking studies had been carried out through AutoDock 4.2. 
Results: About 6 compounds showed drug-likeness by satisfying Lipinski’s properties. The comparative molecular docking studies were done for 6 
compounds which showed drug-likeness through AutoDock 4.2. The comparison reflected that flavonoid and stilbene derivatives bind in the active 
site region of COX-2 with good binding energy. 
Conclusion: The in silico studies on compounds reported from Cissus quadrangularis showed that they possess potential medicinal values with anti-
inflammatory properties which form insights to develop new leads for COX-2 inhibition. 
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INTRODUCTION 
Cissus quadrangularis Linn., is commonly known as Asthisamhari, a 
succulent plant belonging to family Vitaceae [1]. Cissus 
quadrangularis has medicinal properties and it is used in the 
management of weight loss, metabolic syndrome and in Ayurveda 
for complaints of back and spine [2,3,4].The extract from Cissus 
quadrangularis can be used as analgesic, anti-inflammatory and 
antipyretic compound [5]. The extract contains triterpenes, 
flavonoids and stilbenes [6,7,8]. Several biologically active 
compounds were isolated and they have proved to be responsible 
for various pharmacological activities [9]. In this work, we have 
illustrated the binding potential of these compounds as anti-
inflammatory molecules by studying their interaction with the COX-
2 enzyme. 
COX-1 and COX-2 are two isoforms of cyclooxygenase enzyme which 
is crucial for the production of prostaglandins [10]. COX-1 is 
involved in protecting the stomach lining and COX-2 is involved in 
the inflammatory pain found in Central nervous system and in 
inflammatory cells [11]. Non-steroidal anti-inflammatory drugs 
(NSAIDs) inhibit COX-2 enzymes but result in various side effects 
such as gastro-intestinal and renal functional suppression. Thus, 
there is a need to identify plant-derived compounds without any 
side effects. Plants form primary source of medicine for 65-75% of 
the world’s population for the treatment of various diseases. A series 
of new compounds can be produced by traditional synthesis but it is 
time consuming and at high cost. Hence screening of small molecule 
databases of novel compounds is an alternative process [12]. 
The drug-likeness of plant derived compounds can be predicted by 
Lipinski’s rule of five which refers to the similarity of compounds to 
oral drugs. Molecular docking plays an important role in the rational 
drug design. It predicts the binding orientation of small drug targets 
to their protein targets. The anti-inflammatory activity of Urosolic 
acid, a plant derived pentacyclic triterpenoid compound is revealed 
by binding mechanism of the compound with COX-2 enzyme 
[13].Molecular docking studies on biologically active compounds 
from plant Litsea Genus against COX-2 enzyme were also done which 
proves their anti-inflammatory property [14]. In the present study, 
we have studied the drug-likeness of compounds from Cissus 
quadrangularis using Lipinski’s rule of five and the binding 
mechanism of the compounds with COX-2 enzymes using molecular 
docking. 
MATERIALS AND METHODS 
Cissus quadrangularis derived compounds: 
Compounds selected for this study are (a) Asarone, (b) Luteolin, (c) 
Quercetin, (d) Resveratol, (e) Piceatannol, (f) Kampferol, (g) 
Stigmasterol, (h) Lupeol, (i) Freidalin, (j) Quadrangularin, (k) 
Hexadecanoic acid, (l) Tetradecanoic acid, (m) Phytol, (n) Oleic acid, 
(o) Linoleic acid ethyl ester, (p) Octadecanoic acid ethyl ester. The 
structures and the physiochemical properties of these compounds 
were retrieved from the PubChem database (www.ncbi.nlm. 
nih.gov/pubchem) which is shown in Table 1. 
PubChem is a public database which makes database search for a 
broad range of properties including compound structure, name, 
fragments, molecular weight, chemical formula, X Log P, hydrogen 
bond donor and acceptor count. It has own online editor with smiles 
format and our compounds are converted to. pdb format using this 
converter. 
Lipinski’s properties such as molecular weight, log P and number of 
hydrogen bond donors and acceptors were taken from the PubChem 
database for Cissus quadrangularis derived plant compounds. 
COX-2 enzyme protein structure: 
The 3 dimensional structure of the COX-2 enzyme was taken from 
the Protein Data Bank (PDB) database (www.rcsb.pdb) which is 
given in Figure 1. The RCSB PDB is a repository for the 3D structural 
data of large biological macromolecules such as proteins and nucleic 
acids. It provides simple and advanced searches based on 
annotations related to sequence, structure and function The PDB ID 
is 6cox which is a complex of COX-2 enzyme with selective inhibitor 
SC-558 [15]. 
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Fig. 1: Cyclooxygenase-2 (Prostaglandin Synthase-2) in complex 
with a COX-2 selective inhibitor 
 
The active site region of COX-2 enzyme is given in Figure 2. The 
docking process was done by submitting the pdb coordinates of 
protein and ligand to AutoDock 4.2. The binding energy was 
obtained for each ligand and the contact analysis of the docked 
complexes done using Discovery Studio 3.1 visualizer. 
Docking Studies – AutoDock 4.2 
Molecular docking studies were performed for the active plant 
components with COX-2 enzyme by AutoDock 4.2. It is an automated 
docking tool which works by Lamarckian Genetic Algorithm. It 
predicts how small molecules such as substrates or drug candidates 
bind to a receptor of known 3D structures.  
The precise interaction of bioactive agents or candidate molecules 
with their targets is important in the drug development process. 
AutoDock combines two methods to achieve these goals: rapid grid-
based energy evaluation and efficient search of torsional freedom.  
AutoDock 4.2 using the Lamarckian Genetic Algorithm and empirical 
free energy scoring function will provide docking results for ligands 
with approximately 10 flexible bonds. 
 
 
Fig. 2: COX -2 enzyme in complex with selective inhibitor SC-558 
showing the active site region of COX-2 enzyme 
 
Discovery Studio Visualizer 3.1 
Discovery Studio Visualizer is a free, molecular modeling 
environment, for both small molecule and macromolecule 
applications. Discovery Studio is a well-known suite of software for 
simulating molecule and macromolecule systems. It is developed by 
Accelrys which specializes in scientific software products. It is used 
regularly in a range of academic and commercial entities, but is most 
relevant to pharmaceutical and biotechnology industries. It 
generates 2D receptor-ligand interaction plots and analyzes the 
ligand binding patterns between a protein and its bound ligands. 
RESULTS 
Molecular weight, Log P, Number of H bond donor and H bond 
acceptor are tabulated in Table 1. Compounds which obey Lipinski’s 
rule of five were alone subjected to docking experiment. 
 
Table 1: Lipinski properties of the active plant components 
S. No. Compound Molecular weight 
(< than 500 Da) 
Log P 
(< than 5) 
No. of H bond donor 
(< than 5) 
No. of H bond acceptor 
(< than 10) 
1. Asarone 208.25 3 0 3 
2. Luteolin 286.24 1.4` 4 6 
3. Quercetin 302.235 1.5 5 7 
4. Resveratol 228.243 3.1 3 3 
5. Piceatannol 244.24 2.9 4 4 
6. Kampferol 286.23 1.9 4 6 
7. Stigmasterol 412.69 8.6 1 1 
8. Lupeol 426.72 9.9 1 1 
9. Quadrangularin 454.47 4.9 6 6 
10. Freidalin 426.72 9.8 0 1 
11. Hexadecanoic acid 256.42 6.4 1 2 
12. Tetradecanoic acid 228.37 5.3 1 2 
13. Phytol 296.53 8.2 1 1 
14. Oleic acid 282.46 6.5 1 2 
15. Linoleic acid ethyl ester 308.5 7.3 0 2 
16. Octadecanoic acid ethyl ester 312.53 8.9 0 2 
 
Of all the 16 compounds taken from Cissus quadrangularis, six 
compounds (1-6) satisfy Lipinski’s rule of five for drug-likeness 
which is shown in Table 1. The values of the Lipinski’s properties 
which deviated from the Lipinski’s rule of five are highlighted in 
Table 1. Hence compounds which do not follow the Lipinski’s 
properties were not considered for further study. 
The plant components which showed drug-likeness from Cissus 
quadrangularis were a) Asarone, b) Luteolin, c) Quercetin, 
d)Resveratol, e) Piceatannol, and f) Kampferol. The structures of the 
selected compounds are shown in Fig. 3 
The binding energy for each chosen compound with the COX-2 
enzyme using AutoDock 4.2 is given in Table 2. Docking studies 
show that the ligands bind to the active site region of COX-2 enzyme 
with good binding energy. Also all the ligands bind in the same 
hydrophobic pocket which is the active site region of COX-2 enzyme. 
The docking models of the plant compounds a)Asarone, b) Luteolin, 
c) Quercetin, d)Resveratol, e)Piceatannol, f)Kampferol in 3D and 2D 
view are shown in Figure 4,5,6,7,8 and 9. The hydrogen contacts of 
the ligands are tabulated in Table 3.  
Hydrogen bonds indicate the strength of contact between the ligand 
and the receptor and the catalytic activity of an enzyme can be 
predicted by the hydrogen bonds between them. The arrow in the 
2D view denotes the hydrogen bond interactions and the other 

















Fig. 3: The structures of compounds a)Asarone, b) Luteolin, c) Quercetin, d)Resveratol, e)Piceatannol, f)Kampferol. 
 
Table 2: Dock scores of the compounds 
S. No. Compound Dock score 
1 Asarone -5.88 
2 Luteolin -8.62 
3 Quercetin -8.69 
4 Resveratol -7.57 
5 Piceatannol -7.58 
6 Kampferol -3.59 
 
DISCUSSION 
Cyclooxygenase (COX), also known as Prostaglandin (PG) H synthase 
enzymes aids in the conversion of arachidonic acid to prostaglandins 
[16]. Various phyto pathological processes such as inflammatory and 
cardiovascular responses are regulated by prostaglandins. 
Mammalian cells contain COX-1 which is a constitutive enzyme 
whereas COX-2, an inducible enzyme is abundant in macrophages 
and inflammatory sites [17].  
  
Fig. 4: Interaction of Asarone with COX-2 enzyme 
  
Fig. 5: Interaction of Luteolin with COX-2 enzyme 
  
Fig. 6: Interaction of Quercetin with COX-2 enzyme 
 
Table 3: Hydrogen bonds of the ligands 
S. No. Compound Hydrogen contacts 
1 Asarone His 388 
2 Luteoiln His 90, Leu 352, Ser 353, Trp 387, Met 522, 
Gly 526. 
3 Quercetin His 90,Gln 192,Phe 518, Met 522,Ser 530 
4 Resveratol His 90, Gln 192, Ser 353, Phe 518, Gly 526. 
5 Piceatannol His 90, Gln 192, Ser 353, Gly 526. 
6 Kampferol - 
 
COX-2 enzyme plays an important role in carcinogenesis and their 
levels are up-regulated in various carcinomas. Thus, apart from 
inflammation, suppressing levels of COX-2 will be a better method 
for inhibiting carcinogenesis [18]. It has been estimated that NSAIDs 
can cause 3500 hospitalizations and 400 deaths from ulcer bleeding 
per annum in the UK in those aged 60 years and above. The cardiac 
risk for NSAIDs has received a lot of attention both in media and 
within the medical profession. About 30-60% of NSAID users have 
gastrointestinal effects such as dyspepsia and some abdominal 
discomfort [19]. The current study dealt with the in silico 
investigation of Cissus quadrangularis plant compounds for 
inflammation inhibitor to avoid any undesirable side effects. The 
docking studies using AutoDock 4.2 reveals that flavonoids such as 
Luteolin and Quercetin bind strongly to COX-2 enzyme with good 
binding energy of -8.69 and -8.62 respectively. Both form more 
hydrogen bonds on interaction with best cavity. 
The catalytic activity of an enzyme molecule can be accessed by their 
hydrogen bonds in a docking study [20]. Recent studies have shown 
that some flavonoids attenuate inflammatory responses by acting as 
modulators of pro inflammatory gene expression[21]. In addition to 
flavonoids, stilbene derivatives such as Resveratol and Piceatannol 
also proved to be good inhibitors whose hydrogen bonds are with 
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residues His 90, Gln 192, Ser 353, Phe 518 and Gly 526. These 
residues form active site residues for COX-2 enzyme. 
 
 
Fig. 7: Interaction of Resveratol with COX-2. 
 
 




Fig. 9: Interaction of Kampferol with COX-2 
 
The compound asarone, an ether compound also scored good 
binding energy but forms only one hydrogen bond so that its 
structure can be modified to act as a better drug with anti-
inflammatory activity. The foliage leaves of Sabina virginiana 
L.Antoine containing asarone was found to be anti-inflammatory in 
mice paw edema test. Thus asarone can be used as an effective 
inhibitor of COX-2 [22]. Kampferol do not form any hydrogen bond 
and its docking score is also less when compared to other Cissus 
quadrangularis derived compounds. The active compounds from 
Cissus quadrangularis such as Luteolin, Quercetin, Resveratol, 
Piceatannol and Asarone have been found to be more potent as COX-
2 inhibitors through comparative analysis in this docking 
experiment and they hold lots of promise to develop as COX-2 
inhibitor. 
CONCLUSIONS 
The pharmacological activities of the medicinal plant, Cissus 
quadrangularis are antioxidant, anti-inflammatory, antioxidant, free 
radical scavenging, antiulcer, bone healing, analgesic and diuretic. In 
this study, we focused on the anti-inflammatory properties of the 
plant. The plant compounds showed better binding features with the 
COX-2 enzyme. Thus these compounds can be effectively used as 
drugs for treating inflammation. The insights gained in this work can 
be further used in experimental studies to develop leads of drugs 
against COX-2 enzyme. 
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